Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9BWT1: Variant p.Arg274Cys

Cell division cycle-associated protein 7
Gene: CDCA7
Feedback?
Variant information Variant position: help 274 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Cysteine (C) at position 274 (R274C, p.Arg274Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In ICF3. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 274 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 371 The length of the canonical sequence.
Location on the sequence: help CSNSREKIYNRSLGSTCHQC R QKTIDTKTNCRNPDCWGVRG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         CSNSREKIYNRSLGSTCHQCRQKTIDTKTNCRNPDCWGVRG

Mouse                         CSNSREKIYNRSLGSTCHQCRQKTTDTKTNCRNPDCWGIRG

Rat                           CSNSREKIYNRSLGSTCHQCRQKTTDTKTNCRNPDCWGIRG

Bovine                        CNNSREKIYNRSLGSTCHQCRQKTIDTKTNCRNPECWGVRG
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 371 Cell division cycle-associated protein 7
Region 247 – 371 Mediates transcriptional activity
Alternative sequence 208 – 371 Missing. In isoform 4.
Alternative sequence 267 – 316 Missing. In isoform 3.



Literature citations
Mutations in CDCA7 and HELLS cause immunodeficiency-centromeric instability-facial anomalies syndrome.
Thijssen P.E.; Ito Y.; Grillo G.; Wang J.; Velasco G.; Nitta H.; Unoki M.; Yoshihara M.; Suyama M.; Sun Y.; Lemmers R.J.; de Greef J.C.; Gennery A.; Picco P.; Kloeckener-Gruissem B.; Guengoer T.; Reisli I.; Picard C.; Kebaili K.; Roquelaure B.; Iwai T.; Kondo I.; Kubota T.; van Ostaijen-Ten Dam M.M.; van Tol M.J.; Weemaes C.; Francastel C.; van der Maarel S.M.; Sasaki H.;
Nat. Commun. 6:7870-7870(2015)
Cited for: INVOLVEMENT IN ICF3; VARIANTS ICF3 CYS-274; HIS-274; VAL-294 AND HIS-304;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.